Modular Medical, Inc. (MODD) intrinsic value & 10-year financials
Modular Medical, Inc. (MODD) has no Graham intrinsic value right now because the formula needs positive earnings.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $2.32
- Market cap
- $85.7M
- Revenue (FY2025)
- —
- ROIC (10-yr avg)
- 985.0%
- Free cash flow (FY2025)
- -$18.2M
MODD 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | — | -$18.8M | -$0.51 | -$18.2M | — | -508.3% |
| FY2024 | — | -$17.5M | -$0.78 | -$15.7M | — | -627.5% |
| FY2023 | — | -$13.9M | -$0.64 | -$12.6M | — | -1224.4% |
| FY2022 | — | -$18.6M | -$1.37 | -$10.3M | — | 1082.1% |
| FY2021 | — | -$7.4M | — | -$6.0M | — | 559.2% |
| FY2020 | — | -$5.3M | — | -$4.4M | — | 7392.5% |
| FY2019 | — | -$2.5M | — | -$1.9M | — | 3233.3% |
| FY2018 | $0 | -$659.2K | — | -$806.2K | — | -28.5% |
| FY2017 | $0 | -$29.3K | — | -$21.1K | — | -34.8% |
| FY2016 | $0 | -$31.1K | — | — | — | 6.8% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Modular Medical, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Modular Medical, Inc. has historically struggled to out-earn its cost of capital, averaging just 4.3% ROIC.
Modular Medical, Inc. has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.
Benjamin Graham lens
Modular Medical, Inc. is evaluated under Benjamin Graham's defensive framework using SEC EDGAR fundamentals using an 8.5 + 2g earnings multiple and a 5.1% AAA bond-yield baseline.